# Clinical Trial to Evaluate the Safety of Continuous IV Tirofiban in Acute Ischemic Stroke

> **NCT04818944** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **University of Iowa**

## Conditions studied

- Acute Ischemic Stroke
- Ischemic Stroke

## Interventions

- **DRUG:** Tirofiban Hydrochloride
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04818944
- **Lead sponsor:** University of Iowa
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-03-01
- **Primary completion:** 2025-01-01
- **Final completion:** 2025-09-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** PI has left the Institution
- **Last updated:** 2022-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04818944

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04818944, "Clinical Trial to Evaluate the Safety of Continuous IV Tirofiban in Acute Ischemic Stroke". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04818944. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*